Cargando…

Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma

Detalles Bibliográficos
Autores principales: Han, Sojung, Kim, Do Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364361/
https://www.ncbi.nlm.nih.gov/pubmed/32646205
http://dx.doi.org/10.3350/cmh.2020.0096
_version_ 1783559820057509888
author Han, Sojung
Kim, Do Young
author_facet Han, Sojung
Kim, Do Young
author_sort Han, Sojung
collection PubMed
description
format Online
Article
Text
id pubmed-7364361
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Korean Association for the Study of the Liver
record_format MEDLINE/PubMed
spelling pubmed-73643612020-07-27 Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma Han, Sojung Kim, Do Young Clin Mol Hepatol Editorial The Korean Association for the Study of the Liver 2020-07 2020-07-01 /pmc/articles/PMC7364361/ /pubmed/32646205 http://dx.doi.org/10.3350/cmh.2020.0096 Text en Copyright © 2020 by The Korean Association for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Han, Sojung
Kim, Do Young
Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
title Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
title_full Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
title_fullStr Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
title_full_unstemmed Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
title_short Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
title_sort optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364361/
https://www.ncbi.nlm.nih.gov/pubmed/32646205
http://dx.doi.org/10.3350/cmh.2020.0096
work_keys_str_mv AT hansojung optimalsequenceofsystemictherapyaftersorafenibfailureinpatientswithhepatocellularcarcinoma
AT kimdoyoung optimalsequenceofsystemictherapyaftersorafenibfailureinpatientswithhepatocellularcarcinoma